HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Injectafer safely and effectively. See full prescribing information for Injectafer. H. INJECTAFER (ferric carboxymaltoseinjection), for intravenous u se -Initial U.S. Approval: 2024 -
Feraheme [prescribing information]. Waltham, MA: AMAG Pharmaceuticals, Inc.; June 2024. 2. Injectafer [prescribing information]. Shirley, NY
Ferric Carboxymaltose (Injectafer). Order Form. PATIENT PRESCRIBER INFORMATION. Patient Name: DOB: ______ Phone: (H)
Feraheme Prescribing Information. AMAG Pharmaceuticals, Inc. September 2024. 2. Injectafer Prescribing Information. American Regent, Inc
Injectafer (ferric carboxymaltose) in 0.9% NS 250ml IV infusion. Dose REFERENCES: Injectafer Prescribing Information USE BALL POINT PEN FAX TO PHARMACY.
Sections or subsections omitted from the full prescribing information are not . General information about using INJECTAFER safely and effectively.
Feraheme [prescribing information]. Waltham, MA: AMAG Pharmaceuticals, Inc;. September 2024. 5. Injectafer [prescribing information]. Shirley, NY: American
Feraheme [prescribing information]. Waltham, MA: AMAG Pharmaceuticals, Inc.; June. 2024. 2. Injectafer [prescribing information]. Shirley, NY: American
Listed preferred products. References: 1. Injectafer [prescribing information]. American Regent, Inc.; 2024. 2. Venofer [prescribing information]
Comments